Regencell Bioscience Holdings Ltd financial data

Symbol
RGC on Nasdaq
Location
11/F First Commercial Building, 33 35 Leighton Road, Causeway Bay, Hong Kong, Hong Kong
Latest financial report
20-F - Q2 2025 - Oct 31, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 494M shares +3700%
Common Stock, Shares, Outstanding 494M shares 0%
Common Stock, Value, Issued 4.95K USD +3704%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 4.9M USD -39.6%
Property, Plant and Equipment, Net 215K USD +52%
Operating Lease, Right-of-Use Asset 544K USD +542%
Assets 5.76M USD -31.8%
Accrued Liabilities, Current 348K USD +178%
Liabilities, Current 664K USD +243%
Operating Lease, Liability, Noncurrent 232K USD +793%
Liabilities 895K USD +308%
Accumulated Other Comprehensive Income (Loss), Net of Tax -64.8K USD -41.6%
Retained Earnings (Accumulated Deficit) -25.2M USD -16.6%
Stockholders' Equity Attributable to Parent 4.86M USD -40.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.86M USD -40.9%
Liabilities and Equity 5.76M USD -31.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100B shares 0%
Common Stock, Shares, Issued 494M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.42M USD -18.3%
Deferred Tax Assets, Valuation Allowance 4.06M USD +17%
Operating Lease, Liability 544K USD +535%
Lessee, Operating Lease, Liability, to be Paid 574K USD +553%
Property, Plant and Equipment, Gross 1.07M USD +15.9%
Operating Lease, Liability, Current 313K USD +423%
Lessee, Operating Lease, Liability, to be Paid, Year Two 220K USD +777%
Lessee, Operating Lease, Liability, to be Paid, Year One 336K USD +436%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.9K USD +1274%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 3.34M USD +19.8%